Default Category
-
Dia Dia Practimercados: Meeting the Daily Needs at the Base of the Pyramid (A)
Chu, Michael; Garcia-Cuellar, Regina; Gonzalez, Rosa AmeliaCase HBS-313071-EStarting at €8.20
-
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
Daemmrich, Arthur A.Case HBS-711103-EEconomicsSupplement to "U.S. Healthcare Reform: International Perspectives," HBS No. 710-040, updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers.Starting at €8.20
-
Farmacias Similares: Private and Public Health Care for the Base of the Pyramid in Mexico
Chu, Michael; Garcia-Cuellar, ReginaCase HBS-307092-EThis case should be printed in color. Farmacias Similares, serving Mexico's low-income sector, grew to $600 million sales and 3,400 drugstores while deep reforms to help the poor swept the public health system. Adjacent to each store, for $2 per visit, medical clinics provided access to doctors for 2.3 million people a month. Narrates the growth of the chain, examines the reasons for its success, and projects a pro forma of the company's financia...Starting at €8.20
-
Edyficar and Mibanco: The Emergence of M&A in Microfinance (Spanish Version)
Chu, MichaelCase HBS-318S21Knowledge and CommunicationMibanco, un icono de microfinanzas, está a la venta y Edyficar, propiedad de BCP, el mayor banco de Perú, está evaluando su adquisición. Hasta hace poco, tal operación habría sido imaginaria dado el papel preeminente de Mibanco en microfinanzas del Perú que ha hecho el quinto banco más grande del país. Los casos examina qué Mibanco está en el bloque, mientras que también relaciona la evolución de Edyficar y su propia adquisición por parte de BCP ...Starting at €8.20
-
Patrimonio Hoy (Spanish version)
Segel, Arthur I; Chu, Michael; Herrero, Gustavo A.Case HBS-811S14EntrepreneurshipPatrimonio Hoy es un programa dirigido a las necesidades de vivienda de la población de bajos ingresos por CEMEX, empresa mexicana importante y líder en la producción mundial de cemento. Originalmente concebido como un proyecto para comprender los clientes en el segmento de la autoconstrucción mejor, un componente principal de la casa reconocimiento de la capacidad concentrada en barrios de bajos ingresos, Patrimonio Hoy ha generado mexicana y la...Starting at €8.20
-
A Financial Perspective (Spanish version)
Segel, Arthur I; Chu, Michael; Herrero, Gustavo A.Case HBS-208S15EntrepreneurshipPatrimonio Hoy, a program targeting the housing needs of low-income families launched by CEMEX, a major Mexican corporation and a leading global cement company, has gone from a market research project to a highly visible initiative in 22 cities and has earned public recognition. The president of Cemex North America must decide whether it is corporate social responsibility or a new business line. In the process, it allows analysis of the Patrimoni...Starting at €8.20
-
GENTERA: Facing the Digital Age
Chu, Michael; Larangeira, CarlaCase HBS-319092-EStrategyAfter long dominating Mexican microfinance, Compartamos Banco faces the emergence of fintech, just as for the first time its loan portfolio and clients have declined. Enrique Maj s, CEO of GENTERA, the bank s parent company, is keenly aware of the profound changes since the Compartamos IPO in April 2007, when it was valued at $1.5 billion and became the first bank wholly dedicated to microfinance to be quoted in a major stock exchange. Since th...Starting at €8.20
-
Nehemiah Mfg. Co.: Providing a Second Chance
Chu, Michael; Trelstad, Brian; Masko, JohnCase HBS-320008-EBusiness Ethics and Corporate Social ResponsibilityIn 2009, Dan Meyer and Richard Palmer, two veterans of the fast-moving consumer goods (FMCG) industry, founded Nehemiah Manufacturing to build FMCG brands while providing jobs to Cincinnati, Ohio's beleaguered urban core. Two years later, the pair made thStarting at €8.20
-
A Managerial Perspective on Clinical Trials
Daemmrich, Arthur A.Case HBS-709033-EEntrepreneurshipThis note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70 percent of a drug's total development costs, pharmaceutical and biotechnology leaders need to understand clinical trial management. Likewise, with a growing variety of new product i...Starting at €8.20
-
Targanta Therapeutics: Hitting a Moving Target, Teaching Note
Daemmrich, Arthur A.Teaching Note HBS-710006-EEntrepreneurshipTeaching Note for [709002].Starting at €0.00